Skip to main content

Table 6 Household treatment expenditure per visit by provider type (2005 USD) 1

From: Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural Tanzania

Source of care visited

Number of visits

Mean

Median

Range

Government facilities

44

11.79*

5.56^

0 – 87.74

Faith based and NGO facilities

24

24.71*

22.41^

0.09 – 81.04

Private drug outlets

7

13.68

15.4

0.56 – 33.83

Drugs from relatives and friends

2

0

0

0.00 – 0.00

All patients visits 1

77

15.68

8.18

0 – 87.74

  1. 1 Includes those with and without any expenditure.
  2. * Student t-test significant at 1% level between Government and Faith based /NGO Health Facilities.
  3. ^ Mann–Whitney test significant between the two groups at 5% level: Government vs. Faith based / NGO Health Facilities.